Skip to main content
logo
Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
2.040
-0.050 (-2.39%)
At close: Apr 22, 2026, 4:00 PM EDT
2.010
-0.030 (-1.47%)
Pre-market: Apr 23, 2026, 8:21 AM EDT

Gain Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
8613559533765
Market Cap Growth
87.95%131.17%10.59%42.48%-42.36%-
Enterprise Value
66.07115.1548.636.8817.9928.93
Last Close Price
2.043.222.163.273.135.43
PE Ratio
--5.28-2.43-1.91-2.11-3.96
PS Ratio
---960.42265.47391.09
PB Ratio
4.627.307.984.211.971.85
P/TBV Ratio
3.625.726.733.381.971.59
P/FCF Ratio
--7.34-3.10-2.81-2.51-5.18
P/OCF Ratio
--7.34-3.11-2.81-2.53-5.22
EV/Sales Ratio
---668.36128.43175.35
EV/EBITDA Ratio
--6.19-2.40-1.66-1.02-2.09
EV/EBIT Ratio
--6.15-2.39-1.66-1.01-2.09
EV/FCF Ratio
--6.24-2.57-1.95-1.21-2.32
Debt / Equity Ratio
0.030.030.050.050.050.04
Debt / EBITDA Ratio
-0.04-0.04-0.03-0.05-0.07-0.12
Debt / FCF Ratio
-0.04-0.04-0.04-0.05-0.09-0.13
Net Debt / Equity Ratio
-1.08-1.08-1.33-1.25-1.00-1.01
Net Debt / EBITDA Ratio
1.081.080.480.711.072.55
Net Debt / FCF Ratio
1.091.090.520.841.272.83
Asset Turnover
-000.000.000.01
Quick Ratio
6.226.222.663.394.8814.45
Current Ratio
6.636.632.973.595.1114.78
Return on Equity (ROE)
-155.66%-155.66%-204.95%-141.57%-65.52%-67.73%
Return on Assets (ROA)
-111.87%-111.87%-136.01%-104.58%-56.66%-56.93%
Return on Invested Capital (ROIC)
-2006.64%-2006.64%-3246.71%-1578.04%-921.53%-1026.79%
Return on Capital Employed (ROCE)
-135.20%-135.20%-186.09%-132.33%-63.03%-62.96%
Earnings Yield
-23.40%-18.94%-41.20%-52.29%-47.28%-25.23%
FCF Yield
-21.43%-13.63%-32.24%-35.63%-39.82%-19.31%
Buyback Yield / Dilution
-44.08%-44.08%-75.86%-9.49%-16.90%-279.11%
Total Shareholder Return
-44.08%-44.08%-75.86%-9.49%-16.90%-279.11%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q